Role of Liposomes-Based Stem Cell for Multimodal Cancer Therapy.

Cancer Liposomes Osteoarthritis Regenerative medicine Scaffolds Stem cells Tissue engineering

Journal

Stem cell reviews and reports
ISSN: 2629-3277
Titre abrégé: Stem Cell Rev Rep
Pays: United States
ID NLM: 101752767

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 2 12 2019
medline: 17 9 2020
entrez: 2 12 2019
Statut: ppublish

Résumé

The utilization of stem cells as novel carriers to target tissues or organs of interest is a challenging task in delivery system. The composite cellular delivery with diverse signalling molecules as therapeutics increases stem cell capability and possesses the promising potential to augment, modify or commence localized or systemic restoration for vital applications in regenerative medicine. The inherent potential of stem cells to immigrate and reside at wounded site facilitates transportation of genes, polypeptides or nanosized molecules. Liposomes are micro- to nano-lipidic vesicles formed in aqueous solutions to encapsulate complex hydrophilic and lipophilic chemical substances. Moreover, these novel nanocarriers provide safer and efficient delivery of bioactives together with their potential applications in vaccine production, cosmeceuticals, imaging and diagnostic purpose. Tissue engineering promotes rejuvenation process and involves the synchronized utilization of cells with 3D bio-material scaffolds to fabricate living structures. This strategy requires regulated stimulus of cultured cells through combined mechanical signals and bioactive agents. This review highlights and summarizes the mechanism involved in stem cell migration, strategies to enhance homing, safety and efficacy studies of stem cells in various disease models and discusses the potential role of liposomes in prolonged and localized delivery of bioactives for regenerative medicines and tissue engineering techniques. Graphical Abstract Role of PEGylated liposomes in cancer stem cell therapy.

Identifiants

pubmed: 31786749
doi: 10.1007/s12015-019-09933-z
pii: 10.1007/s12015-019-09933-z
doi:

Substances chimiques

Liposomes 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-117

Références

Trends Biotechnol. 2010 Jan;28(1):28-36
pubmed: 19896228
Biomaterials. 2012 Mar;33(9):2608-28
pubmed: 22209557
Wound Repair Regen. 2004 Jan-Feb;12(1):80-5
pubmed: 14974968
Langmuir. 2008 Apr 15;24(8):4092-6
pubmed: 18338908
Wound Repair Regen. 2015 Jan-Feb;23(1):82-9
pubmed: 25581571
Nanoscale Res Lett. 2013 Feb 22;8(1):102
pubmed: 23432972
Int J Nanomedicine. 2013;8:495-503
pubmed: 23439842
Biol Blood Marrow Transplant. 2014 Mar;20(3):375-81
pubmed: 24321746
J Pharm Sci. 2008 Feb;97(2):726-45
pubmed: 17823947
Adv Drug Deliv Rev. 2006 Jul 7;58(4):500-14
pubmed: 16759734
ACS Appl Mater Interfaces. 2015 Aug 5;7(30):16792-801
pubmed: 26173814
Cell Stem Cell. 2008 Mar 6;2(3):198-200
pubmed: 18371444
J Nanobiotechnology. 2011 Feb 09;9:4
pubmed: 21542946
J Drug Deliv. 2011;2011:326497
pubmed: 21490748
Adv Exp Med Biol. 2018;1089:59-72
pubmed: 29516308
Nanomaterials (Basel). 2017 Jul 22;7(7):
pubmed: 28737672
Front Pharmacol. 2015 Dec 01;6:286
pubmed: 26648870
J Control Release. 2008 Jul 2;129(1):18-25
pubmed: 18466993
Stem Cells Transl Med. 2017 Jun;6(6):1445-1451
pubmed: 28452204
Nano Lett. 2012 Jul 11;12(7):3587-91
pubmed: 22716029
Cell Mol Life Sci. 2015 Dec;72(24):4759-70
pubmed: 26350342
Mol Ther Methods Clin Dev. 2017 Jun 23;6:102-111
pubmed: 28725658
Sci Rep. 2016 Sep 28;6:33784
pubmed: 27677463
Oncotarget. 2014 Aug 15;5(15):6497-511
pubmed: 25153726
Biochem Biophys Res Commun. 2010 Oct 29;401(4):509-15
pubmed: 20869949
Biomaterials. 2014 Jan;35(1):174-84
pubmed: 24120047
J Neuroimmunol. 2008 Jul 31;198(1-2):31-8
pubmed: 18508132
J R Soc Interface. 2014 Dec 6;11(101):20140459
pubmed: 25401172
J Exp Ther Oncol. 2009;8(1):53-63
pubmed: 19827271
Pharm Res. 2002 Dec;19(12):1808-14
pubmed: 12523658
BMC Musculoskelet Disord. 2016 May 26;17:230
pubmed: 27229856
Mol Pharm. 2010 Feb 1;7(1):3-11
pubmed: 19719324
Mol Cancer Ther. 2018 Jul;17(7):1475-1485
pubmed: 29695632
Blood. 2017 Mar 9;129(10):1380-1388
pubmed: 28073785
J Biol Chem. 2005 Apr 22;280(16):15619-27
pubmed: 15695518
Biomaterials. 2012 Jan;33(2):565-82
pubmed: 21983136
World J Stem Cells. 2016 Mar 26;8(3):73-87
pubmed: 27022438
Int J Pharm. 2008 Nov 19;364(1):87-93
pubmed: 18771719
J Pharm Pharm Sci. 2010;13(2):136-51
pubmed: 20816001
Biophys J. 2004 Apr;86(4):2179-87
pubmed: 15041658
J Dent Res. 2017 Jun;96(6):601-609
pubmed: 28414563
Adv Exp Med Biol. 2016;854:563-9
pubmed: 26427460
Stem Cell Rev Rep. 2019 Oct;15(5):637-651
pubmed: 31254166
Orthod Craniofac Res. 2005 Aug;8(3):183-90
pubmed: 16022720
Curr Gene Ther. 2011 Feb;11(1):46-57
pubmed: 21182464
Clin Pharmacol Ther. 2007 Sep;82(3):252-64
pubmed: 17671448
Adv Wound Care (New Rochelle). 2015 Nov 1;4(11):623-630
pubmed: 26543676
Tissue Eng Part B Rev. 2016 Apr;22(2):101-13
pubmed: 26714410
Nanomedicine (Lond). 2012 Jul;7(7):1045-66
pubmed: 22846091
Mol Ther. 2010 May;18(5):1026-34
pubmed: 20068549
Curr Opin Cell Biol. 2009 Oct;21(5):636-44
pubmed: 19523798
World J Stem Cells. 2018 May 26;10(5):43-56
pubmed: 29849930
ACS Nano. 2014 May 27;8(5):4403-14
pubmed: 24754735
J Pharm Pharmacol. 2003 Apr;55(4):453-60
pubmed: 12803766
Biomed Pharmacother. 2018 Jan;97:38-44
pubmed: 29080456
J Biosci Bioeng. 2005 Jul;100(1):1-11
pubmed: 16233845
Stem Cells Int. 2016;2016:9176357
pubmed: 26649054
Stem Cells Int. 2015;2015:734731
pubmed: 26300923
Int J Nanomedicine. 2012;7:5315-25
pubmed: 23071393
Drug Deliv. 2016 Jun;23(5):1676-98
pubmed: 26289212
ACS Nano. 2014 Aug 26;8(8):8082-94
pubmed: 25046548
Stem Cell Res Ther. 2016 Jan 11;7:7
pubmed: 26753925
Biochem J. 2002 Aug 15;366(Pt 1):333-41
pubmed: 12030844
Mol Ther Methods Clin Dev. 2014 Apr 30;1:14013
pubmed: 25558460
J Inherit Metab Dis. 2017 Jul;40(4):543-554
pubmed: 28560469
Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2210-5
pubmed: 21757660
Ther Deliv. 2017 Jun;8(6):425-445
pubmed: 28530145
Stem Cells Transl Med. 2018 Dec;7(12):857-866
pubmed: 30255989
Colloids Surf B Biointerfaces. 2012 Jun 15;95:75-81
pubmed: 22484065
Artif Cells Nanomed Biotechnol. 2017 Jun;45(4):788-799
pubmed: 28278586
Stem Cell Res Ther. 2017 Aug 30;8(1):191
pubmed: 28854961
Stem Cells. 2005 Oct;23(9):1324-32
pubmed: 16210409
Expert Opin Biol Ther. 2010 Dec;10(12):1663-79
pubmed: 21058931
Trials. 2017 Mar 7;18(1):108
pubmed: 28270226
J Clin Oncol. 1999 Sep;17(9):2639-48
pubmed: 10561337
Gene Ther. 2010 Nov;17(11):1363-71
pubmed: 20520650
Methods. 2004 Jun;33(2):95-103
pubmed: 15121163
Int J Nanomedicine. 2015 Feb 02;10:975-99
pubmed: 25678787
Cell Adh Migr. 2012 Jan-Feb;6(1):39-48
pubmed: 22647939

Auteurs

Pankaj Mandpe (P)

Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM'S NMIMS, V. L. Mehta road, Vile Parle (W), Mumbai, India.

Bala Prabhakar (B)

Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM'S NMIMS, V. L. Mehta road, Vile Parle (W), Mumbai, India.

Pravin Shende (P)

Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM'S NMIMS, V. L. Mehta road, Vile Parle (W), Mumbai, India. shendepravin94@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH